Ovarian cancer arises in fallopian tube of knockout mice

February 13, 2012

(Medical Xpress) -- The most deadly form of "ovarian" cancer arises in the fallopian tubes – not the ovaries – of knockout mice that lack two genes associated with the disease, said researchers led by Baylor College of Medicine in a report that appears online in the journal Proceedings of the National Academy of Sciences.

"While many questions remain about the steps in the pathogenesis of this deadly disease in women, our study opens a new door to understanding the molecular origins and progression of high-grade serous epithelial cancer," said Dr. Martin Matzuk, vice chair and professor of pathology & immunology, molecular and human genetics, molecular and cellular biology, and pharmacology at BCM.

"Our mouse model will help us translate this information into direct patient care, changing the way we screen, diagnose, and treat this deadliest form of 'ovarian' cancer." Matzuk is also the corresponding author of the report and a member of the NCI-designated Dan L. Duncan Cancer Center at BCM.

Deadliest gynecological cancer

Ovarian cancer is the ninth most common cause of cancer among women and the fifth leading cause of cancer death. It is the deadliest gynecological cancer. High-grade serous epithelial ovarian cancer accounts for 70 percent of all deaths attributed to ovarian cancer. In women, are narrow sections of the female reproductive tract that connect the ovary to the uterus. During normal reproduction, oocytes that are ovulated from the ovary are fertilized in the fallopian tube.

However, in this study, Matzuk and his colleagues show that the disease that is typically called "ovarian" cancer does not arise within the ovary but instead from the fallopian tubes in mice that lack two genes – Dicer and Pten. Mutations in each gene have recently been shown to be altered in women with high-grade serious .

Hope to identify cellular markers

Further analysis of these mice show that the tumors originate in fallopian tube cells internal to the surface layer, called the stroma. "The study suggests that these epithelial cancers (those believed to arise from the cells that line body cavities and cover flat surfaces of the body) derive from stem cells in the stroma via a novel differentiation mechanism," said Dr. Jaeyeon Kim, first author on this report and a post-doctoral fellow in Matzuk's laboratory at BCM. "We hope to use our understanding of how these cancers initiate and grow to identify cellular markers that could help in early detection and screening for this deadly disease. We are also using the mouse model and cancer cells derived from these mice for discovering novel combinations of drugs to eradicate this deadly disease."

Explore further: Researchers discover antibody that may help detect ovarian cancer in earliest stages

Related Stories

Researchers discover antibody that may help detect ovarian cancer in earliest stages

August 16, 2011
Using a new approach to developing biomarkers for the very early detection of ovarian cancer, researchers at Rush University Medical Center have identified a molecule in the bloodstream of infertile women that could one day ...

Predicting cellular response to paclitaxel in epithelial ovarian cancer

November 16, 2011
(Medical Xpress) -- New research findings by UCD scientists published online in the Journal of Pathology may help clinicians predict how patients with high grade, serous, epithelial ovarian cancer will respond to paclitaxel ...

Evolving ovarian cancer cells 'dodge' treatment with chemotherapy

December 20, 2011
(Medical Xpress) -- Cancer Research UK scientists have discovered that the commonest type of ovarian cancer evolves at a startling rate, which may allow cancer cells to ‘dodge’ the current standard treatment, reveals ...

Recommended for you

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

One in four U.S. seniors with cancer has had it before

November 22, 2017
(HealthDay)—For a quarter of American seniors, a cancer diagnosis signals the return of an old foe, new research shows.

Combination immunotherapy targets cancer resistance

November 22, 2017
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.